38089 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 23
13:14 UTC
|
CMPX
Compass Therapeutics
|
◎ Target | Reni J. Benjamin not yet tracked | Market Outperform | $4.00 |
|
Sep 23
13:14 UTC
|
CMI
Cummins
|
◎ Target | Tami Zakaria ★★★☆☆ #1326 | Neutral | $690.00→ $600.00-13.0% |
|
Sep 23
13:14 UTC
|
CGNX
Cognex
|
◎ Target | Richard Eastman not yet tracked | Neutral | $78.00→ $70.00-10.3% |
|
Sep 23
13:14 UTC
|
BP
BP
|
◎ Target | firm only | Neutral→ Overweight | GBX 550→ GBX 675+22.7% |
|
Sep 23
13:14 UTC
|
BFAM
Bright Horizons Family Solutions
|
◎ Target | Toni Kaplan ★★★★☆ #549 | Underweight | $68.00→ $66.00-2.9% |
|
Sep 23
13:14 UTC
|
AZO
AutoZone
|
◎ Target | Tristan Thomas-Martin not yet tracked | Outperform | $4,000.00→ $3,500.00-12.5% |
|
Sep 23
13:14 UTC
|
AZO
AutoZone
|
◎ Target | David Bellinger ★★★☆☆ #1234 | Neutral | $3,200.00→ $3,000.00-6.2% |
|
Sep 23
13:14 UTC
|
AZO
AutoZone
|
◎ Target | Bobby Griffin ★★★★☆ #916 | Strong-Buy | $4,000.00→ $3,700.00-7.5% |
|
Sep 23
13:14 UTC
|
AZO
AutoZone
|
◎ Target | Justin Kleber ★★☆☆☆ #2584 | Neutral | $3,600.00→ $3,400.00-5.6% |
|
Sep 23
13:14 UTC
|
AZO
AutoZone
|
◎ Target | Steven Forbes ★★★☆☆ #1083 | Buy | $4,000.00→ $3,750.00-6.2% |
|
Sep 23
13:14 UTC
|
AZO
AutoZone
|
◎ Target | Seth Sigman ★★★☆☆ #1695 | Overweight | $3,637.00→ $3,400.00-6.5% |
|
Sep 23
13:14 UTC
|
ACN
Accenture
|
◎ Target | Keith Bachman ★★★★★ #115 | Market Perform | $150.00→ $200.00+33.3% |
|
Sep 23
12:14 UTC
|
WIX
Wix.com
|
◎ Target | Bernie McTernan ★★☆☆☆ #2836 | Buy | $80.00→ $95.00+18.8% |
|
Sep 23
12:14 UTC
|
VLO
Valero Energy
|
◎ Target | Neil Mehta ★★★★☆ #524 | Buy | $365.00→ $457.00+25.2% |
|
Sep 23
12:14 UTC
|
TLSI
TriSalus Life Sciences
|
◎ Target | Swayampakula Ramakanth ★★☆☆☆ #2745 | Buy | $11.00→ $12.00+9.1% |
|
Sep 23
12:14 UTC
|
RTX
RTX
|
◎ Target | Douglas Harned ★★★☆☆ #2253 | Market Perform | $232.00→ $223.00-3.9% |
|
Sep 23
12:14 UTC
|
RKH
Rockhopper Exploration
|
◎ Target | firm only | Buy | GBX 130→ GBX 135+3.8% |
|
Sep 23
12:14 UTC
|
RBLX
Roblox
|
◎ Target | Bernie McTernan ★★☆☆☆ #2836 | Buy | $50.00→ $55.00+10.0% |
|
Sep 23
12:14 UTC
|
META
Meta Platforms
|
◎ Target | Deepak Mathivanan ★★★☆☆ #2001 | Overweight | $680.00→ $860.00+26.5% |
|
Sep 23
12:14 UTC
|
META
Meta Platforms
|
◎ Target | Justin Patterson ★★★☆☆ #1551 | Overweight | $780.00→ $900.00+15.4% |
|
Sep 23
12:14 UTC
|
KMX
CarMax
|
◎ Target | Daniela Haigian ★★★☆☆ #1171 | Equal Weight | $44.00→ $47.00+6.8% |
|
Sep 23
12:14 UTC
|
KLC
KinderCare Learning Companies
|
◎ Target | Toni Kaplan ★★★★☆ #549 | Underweight | $2.50→ $2.00-20.0% |
|
Sep 23
12:14 UTC
|
KBH
KB Home
|
◎ Target | Rafe Jadrosich ★★☆☆☆ #2327 | Neutral | $56.00→ $54.00-3.6% |
|
Sep 23
12:14 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Judah Frommer ★★★☆☆ #1437 | Overweight | $50.00→ $57.00+14.0% |
|
Sep 23
10:13 UTC
|
STAN
Standard Chartered
|
◎ Target | firm only | Neutral | GBX 2,230→ GBX 2,370+6.3% |
|
Sep 23
10:13 UTC
|
SMIN
Smiths Group
|
◎ Target | firm only | Buy | GBX 3,000→ GBX 3,200+6.7% |
|
Sep 23
10:13 UTC
|
SDLF
Standard Life
|
◎ Target | firm only | Sec→ r perform | GBX 885→ GBX 970+9.6% |
|
Sep 23
10:13 UTC
|
NWG
NatWest Group
|
◎ Target | firm only | Buy | GBX 840→ GBX 860+2.4% |
|
Sep 23
10:13 UTC
|
KGF
Kingfisher
|
◎ Target | firm only | Hold | GBX 295→ GBX 320+8.5% |
|
Sep 23
10:13 UTC
|
HSBA
HSBC
|
◎ Target | firm only | Neutral | GBX 1,570→ GBX 1,640+4.5% |
|
Sep 23
10:13 UTC
|
HAS
Hays
|
◎ Target | firm only | Neutral | GBX 33→ GBX 65+97.0% |
|
Sep 23
10:13 UTC
|
BP
BP
|
◎ Target | firm only | Overweight | GBX 550→ GBX 675+22.7% |
|
Sep 23
10:13 UTC
|
BOKU
Boku
|
◎ Target | firm only | Buy | GBX 200→ GBX 210+5.0% |
|
Sep 23
10:13 UTC
|
BARC
Barclays
|
◎ Target | firm only | Neutral | GBX 510→ GBX 500-2.0% |
|
Sep 23
10:13 UTC
|
ABF
Associated British Foods
|
◎ Target | firm only | Sec→ r perform | GBX 1,550→ GBX 1,520-1.9% |
|
Sep 23
00:12 UTC
|
XMTR
Xometry
|
◎ Target | Scott Devitt ★★☆☆☆ #2893 | Buy | $110.00→ $120.00+9.1% |
|
Sep 23
00:12 UTC
|
WBD
Warner Bros. Discovery
|
◎ Target | Sean Diffley ★★★☆☆ #1758 | Equal Weight | $29.00→ $31.00+6.9% |
|
Sep 23
00:12 UTC
|
WAL
Western Alliance Bancorporation
|
◎ Target | Benjamin Gerlinger not yet tracked | Buy | $98.00→ $95.00-3.1% |
|
Sep 23
00:12 UTC
|
VRDN
Viridian Therapeutics
|
◎ Target | Lisa Walter ★★☆☆☆ #2556 | Outperform | $36.00→ $38.00+5.6% |
|
Sep 23
00:12 UTC
|
TYRA
Tyra Biosciences
|
◎ Target | Mitchell S. Kapoor not yet tracked | Buy | $30.00→ $29.00-3.3% |
|
Sep 23
00:12 UTC
|
TWLO
Twilio
|
◎ Target | Catharine Trebnick ★★★★☆ #364 | Buy | $275.00→ $290.00+5.5% |
|
Sep 23
00:12 UTC
|
TWLO
Twilio
|
◎ Target | Derrick Wood ★★★★★ #207 | Buy | $260.00→ $300.00+15.4% |
|
Sep 23
00:12 UTC
|
TPB
Turning Point Brands
|
◎ Target | Ian Zaffino ★★★☆☆ #1718 | Outperform | $130.00→ $90.00-30.8% |
|
Sep 23
00:12 UTC
|
TCBI
Texas Capital Bancshares
|
◎ Target | Benjamin Gerlinger not yet tracked | Neutral | $107.00→ $104.00-2.8% |
|
Sep 23
00:12 UTC
|
TBTG
The Beauty Tech Group
|
◎ Target | firm only | Buy | GBX 545→ GBX 600+10.1% |
|
Sep 23
00:12 UTC
|
TA
TransAlta
|
◎ Target | firm only | C$26.00→ C$24.50-5.8% | |
|
Sep 23
00:12 UTC
|
SYK
Stryker
|
◎ Target | Mathew Blackman ★★★★☆ #656 | Hold | $355.00→ $298.00-16.1% |
|
Sep 23
00:12 UTC
|
STZ
Constellation Brands
|
◎ Target | Lauren Lieberman ★★★☆☆ #1139 | Equal Weight | $132.00→ $122.00-7.6% |
|
Sep 23
00:12 UTC
|
STZ
Constellation Brands
|
◎ Target | Filippo Falorni ★★★★★ #259 | Buy | $185.00→ $165.00-10.8% |
|
Sep 23
00:12 UTC
|
STAA
STAAR Surgical
|
◎ Target | Young Li ★★☆☆☆ #2551 | Buy | $28.00→ $23.00-17.9% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.